Rare diseases
Investigational molecules
Locations
Langenbeckstrasse 1, Oberstadt, 55131 Mainz, Germany
Center For Pediatric And Adolescent Medicine Of The Johannes Gutenberg University Mainz in Mainz, Germany specialises in clinical trials of conditions such as Metabolic dysfunction-associated steatohepatitis, Acute myeloid leukaemia, Systemic lupus erythematosus, Hidradenitis, and other specialisations. This site conducts important research.
At the Center For Pediatric And Adolescent Medicine Of The Johannes Gutenberg University Mainz, clinical research focuses on malignant extracranial germ cell tumours within the broader field of neoplasms. The studies are aimed at improving treatment choices for children and adolescents affected by these rare cancers.
The site in Mainz contributes to cancer research that is both clinically focused and highly specialized, with an emphasis on finding better ways to treat rare pediatric and adolescent tumors.
Clinical trials currently enrolling participants at this site.
GermanyA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
GermanyEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
GermanyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
GermanyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GermanyA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
GermanyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
GermanyA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
GermanyStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
GermanyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
GermanyLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
